Status:
UNKNOWN
Digital 3D Reconstruction Predicts Small Bowel Length
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions:
Small Intestine Length Measurement
Eligibility:
All Genders
16-65 years
Brief Summary
The prevalence of type 2 diabetes mellitus (T2DM) has been increasing annually worldwide, and the prevalence of diabetes has reached 11.6% in China. Laparoscopic Roux-en-Y gastric bypass (RYGB) is sti...
Eligibility Criteria
Inclusion
- Patients eligible for surgical treatment of T2DM were selected based on the Chinese Guidelines for the Surgical Treatment of Obesity and Type 2 Diabetes (2019 )
Exclusion
- Adhesions, peritonitis, and patients who have had bowel resection (small intestine, colon or rectum) that hinder the measurement of the entire intestinal length
- Non-weight loss surgery patients whose incision is less than 6 cm are not suitable for measuring the length of the small intestine.
Key Trial Info
Start Date :
October 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 2 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05338567
Start Date
October 2 2019
End Date
October 2 2023
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daping hospital
Chongqing, China, 400042